CRISPR Webinar

Gene Editing for Rare Skin Disorder Junctional Epidermolysis Bullosa | Wed. Sept. 21, 2022 | 3:00 pm – 4:30 pm CEST / 9:00 am – 10:30 am EST | Free CMN Live Webinar

On-demand webinar is available - Follow this link

Gene Editing for Rare Skin Disorder Junctional Epidermolysis Bullosa

Webinar Programme:

15.00 Welcome and introduction by CRISPR Medicine News
15.05 Johannes Bischof, Dr., EB House Austria | Gene Editing for Rare Skin Disorder Junctional Epidermolysis Bullosa
15.50 Q & A with Johannes Bischof
16.25 Close by CRISPR Medicine News

Speaker | Title:

Johannes Bischof, Dr., EB House Austria, Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Austria | Gene Editing for Rare Skin Disorder Junctional Epidermolysis Bullosa

CMN interview

CMN Webinar: Gene Editing for Rare Skin Disorder Junctional Epidermolysis Bullosa

Speakers

Johannes Bischof, Dr., EB House Austria

Dr. Johannes Bischof, Postdoc at the Koller working group for Epidermolysis Bullosa Research

EB House Austria, Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Austria

Read our CMN interview with Dr. Bischof from July 2022.

Interested in hosting a webinar on CMN?

+20k readers | +10k followers | Top-1 CRISPR News Site | sales@crisprmedicinenews.com

CMN Webinars - Your Gateway to CRISPR Medicine

If you have any questions or request for webinars, please contact us at: sales@crisprmedicinenews.com

Future CMN Webinars will be listed here.

Always stay updated - Sign up to weekly newsletter.

Webinar

PRCSR CRISPR: Vivlion's CRISPR-enabled Discovery...

Nov. 28, 2023

Webinar | Wednesday December 6, 2023 | 3:00 pm–4:30 pm CET / 9:00 am–10:30 am EDT

Webinar

CRISPR Helps Decode the Epigenetic Mysteries of...

Nov. 9, 2023

Webinar | Wednesday November 22, 2023 | 3:00 pm–4:00 pm CET / 9:00 am–10:00 am EDT

Webinar

A Dual CRISPR Strategy Eliminates HIV in Humanised...

Nov. 6, 2023

Webinar | Tuesday November 7, 2023 | 3:00 pm–4:00 pm CET / 9:00 am–10:00 am EDT

CMN Articles - Delivery

Highlight: In Utero Nanoparticle Delivery Enables...

CMN Briefs

Oct. 28, 2024

Delivering mRNA via acid-degradable nanoparticles offers a new frontier in prenatal gene editing, setting the stage for treatments targeting the root...

Engineered Polymers Show Promise for Systemic mRNA...

CMN Interview

Oct. 21, 2024

Scientists engineered nanoparticles capable of delivering genetic material to lung cells with high efficiency when administered intravenously. Based...

Thermostable Cas9 Enhances RNP Performance in Lung...

CMN Briefs

Oct. 17, 2024

Jennifer Doudna and colleagues have engineered a thermostable Cas9 variant, iGeoCas9, which dramatically enhances genome editing efficiency in...

Quantum dots improve CRISPR delivery to microglia

CMN Briefs

Oct. 15, 2024

Researchers in South Korea have developed a cadmium selenide (CdSe) quantum dot (Qdot) system to deliver CRISPR-Cas9 for gene editing in microglia,...

Highlight: CRISPR reduces the cause of blindness...

CMN Briefs

Oct. 7, 2024

In a move to potentially treat blindness, researchers have used CRISPR-Cas9 technology to permanently disrupt VEGFA expression in the eyes of rhesus...

Droplet cell mechanoporation boosts CRISPR...

CMN Briefs

Sep. 16, 2024

Researchers in South Korea have introduced a novel microfluidic platform, termed Droplet Cell Pincher (DCP), to enhance CRISPR-Cas9 genome editing....

Therapeutic Gene Editing. A Lot Done, a Lot More...

CMN Interview

Feb. 5, 2024

For the inaugural episode of CMN Live on 26th January 2024, we spoke with Eric Kmiec, Ph.D. about the successes of therapeutic gene editing to date,...

Gene-Editing Tools: Delivery Methods and...

CMN Special

Jan. 22, 2024

Gene-editing systems, especially CRISPR-Cas9, have revolutionised genome editing, offering potential cures for genetic disorders, cancers, and other...